Markets.com Logo

GSK

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    40.1454$
  • Previous Close
    40.2828$
  • 52 Week Change
    12.04$
  • Day Range
    -0.14$
  • 52 Week High/Low
    30.6792$ - 42.7155$
  • Dividend Per Share
    0.0411
  • Market cap
    80 747 M$
  • EPS
    1.2405
  • Beta
    0.268
  • Volume
    --

About

GSK.US represents GlaxoSmithKline plc's American Depositary Shares (ADS) traded on the New York Stock Exchange (NYSE). Each ADS represents two ordinary shares of GlaxoSmithKline, a global biopharmaceutical company headquartered in the UK. Investing in GSK.US provides exposure to the company's revenue streams from the development, manufacture, and marketing of pharmaceuticals, vaccines, and consumer healthcare products. The stock's performance is influenced by factors such as drug development success, regulatory approvals, patent expirations, and overall market conditions within the healthcare sector.

Yen's Safe-Haven Status Under Scrutiny: Is the Japanese Currency Losing Its Luster?

Liam James|--

Gold Price Surge: Drivers and Future Outlook Explained

Emma Rose|--

Fed's Powell Navigates Inflation vs. Labor Market Tightrope

Liam James|--

Dollar's Surge Shakes Up Hedge Fund Strategies: A Look at Currency Movements and Impacts

Sophia Claire|--

US Consumer Holiday Spending Outlook 2024: A Grim Forecast?

Sophia Claire|--

Gold as a Hedge Against Stock Market Peak: Still a Safe Haven?

Sophia Claire|--

Central Banks: Bitcoin and Gold Reserves by 2030?

Emma Rose|--

Factors

Drug Pipeline Success: Positive clinical trial results and regulatory approvals for new drugs typically boost GSK's stock price, reflecting future revenue potential.

Competition: Intense competition from generic and biosimilar drugs can erode market share and pressure pricing, negatively affecting GSK's revenues and stock value.

Economic Conditions: Economic downturns can impact healthcare spending, potentially reducing demand for GSK's products and affecting its financial performance.

Regulatory Changes: Changes in healthcare regulations, such as pricing controls or drug approval processes, can significantly influence GSK's profitability and stock price.

Patent Expirations: When patents on key drugs expire, GSK faces competition from cheaper generics, which reduces revenue and stock value.

Mergers and Acquisitions: Strategic acquisitions or mergers can alter GSK's market position and future prospects, impacting investor sentiment and stock price.

Dividend Policy: GSK's dividend payouts can influence investor demand for its stock, as a higher dividend yield may attract income-seeking investors.

Global Health Crises: Pandemics or outbreaks of infectious diseases can create both opportunities and challenges for GSK, affecting its research priorities and product demand.

Research and Development Spending: The level of investment GSK makes in R&D can signal its commitment to innovation and future growth, potentially influencing stock price.

Litigation and Legal Issues: Lawsuits or legal challenges related to GSK's products or business practices can create uncertainty and negatively impact investor confidence.

People Also Watch

Latest news

Japan Leadership Race: Koichi-Ishin Negotiations Shape Government's Course

Sophia Claire|--

Italy Strikes Gold: Record High Gold Reserves Offer Unexpected Financial Windfall

Ava Grace|--

Precious Metals Surge Amid Uncertainty: A Look at Gold, Silver, and Platinum Gains

Emma Rose|--

Latest Education Articles

 Japanese Yen analysis & forecast 2025/2026: Is USD JPY a good pair to trade?

Japanese Yen analysis & forecast 2025/2026: Is USD JPY a good pair to trade?

Ghko B|--
Top 10 Trusted Forex Brokers of 2026: Which Forex Broker is the Best?

Top 10 Trusted Forex Brokers of 2026: Which Forex Broker is the Best?

Ghko B|--
Understanding Dividend Stocks: Top 20 High-Dividend Stocks List 2025

Understanding Dividend Stocks: Top 20 High-Dividend Stocks List 2025

Ghko B|--